References
Petersen, E. E., Daschner, F. D., Pelz, K., Trennhäuser, M.: Erfahrungen mit Lamoxactan in der Gynäkologie. Einsatz als Monotherapeutikum und Konzentrationsbestimmungen im Uterus- und Tubengewebe. Geburtshilfe — Frauenheilkunde 1982, 42: 895–898.
Dismukes, W. E., Karchmer, A. W., Buckley, M. J., Austen, W. G., Swartz, M. N.: Prosthetic valve endocarditis: analysis of 38 cases. Circulation 1973, 48: 365–377.
Braveny, L.: In vitro activity of imipenem — a review. European Journal of Clinical Microbiology 1984, 3: 456–462.
Drusano, G. L., Standiford, H. C., Bustamante, C. J., Forrest, A., Rivera, G., Tatem, B., Schimpff, S. C.: The plasma pharmacokinetics of high dose (1 g) imipenem co-administered with 1 g cilastatin in six normal volunteers. European Journal of Clinical Microbiology 1984, 3: 468–470.
Livingston, W. K., Elliot, A. M., Cobbs, C. G.: In vitro activity of N-formimidoyl thienamycin (MK 0787) against resistant strains ofPseudomonas aerugmosa, Staphyloccocus epidermidis, Serratia marcescens, andEnterococcus spp. Antimicrobial Agents and Chemotherapy 1981, 19: 114–116.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kümmel, A., Schlosser, V., Petersen, E. et al. Pharmacokinetics of imipenem-cilastatin in serum and tissue. Eur. J, Clin. Microbiol. 4, 609–610 (1985). https://doi.org/10.1007/BF02013415
Issue Date:
DOI: https://doi.org/10.1007/BF02013415